MARKET

OMCL

OMCL

Omnicell Com
NASDAQ
49.45
-1.39
-2.73%
After Hours: 49.45 0 0.00% 16:46 12/05 EST
OPEN
50.53
PREV CLOSE
50.84
HIGH
50.57
LOW
48.10
VOLUME
1.04M
TURNOVER
0
52 WEEK HIGH
185.28
52 WEEK LOW
46.19
MARKET CAP
2.21B
P/E (TTM)
48.86
1D
5D
1M
3M
1Y
5Y
Omnicell to Showcase Advanced Services Designed to Deliver Enhanced Medication Management Outcomes at ASHP Midyear 2022
SANTA CLARA, Calif., December 05, 2022--Omnicell to Showcase Advanced Services Designed to Deliver Enhanced Medication Management Outcomes at ASHP Midyear 2022
Business Wire · 1d ago
Omnicell to Present at the Piper Sandler 34th Annual Healthcare Conference
SANTA CLARA, Calif., November 23, 2022--Omnicell to Present at the Piper Sandler 34th Annual Healthcare Conference
Business Wire · 11/23 21:01
Omnicell (NASDAQ:OMCL) stock falls 6.4% in past week as one-year earnings and shareholder returns continue downward trend
It's not a secret that every investor will make bad investments, from time to time. But serious investors should think...
Simply Wall St. · 11/23 10:40
JPMorgan Chase Cuts Price Target on Omnicell to $57 From $140, Maintains Neutral Rating
JPMorgan Chase Cuts Price Target on Omnicell to $57 From $140, Maintains Neutral Rating
MT Newswires · 11/18 10:15
Ray Dalio Stock Portfolio Q3 2022: Top 10 Small-Cap Stocks
In this article, we discuss the top 10 small-cap stocks from Ray Dalio’s Q3 2022 portfolio. If you want to see more stocks in this selection, check out Ray Dalio Stock Portfolio Q3 2022: Top 5 Small-Cap Stocks. According to Royce Investment Partners, altho...
Insider Monkey · 11/15 14:49
Omnicell Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag
Omnicell ( NASDAQ:OMCL ) Third Quarter 2022 Results Key Financial Results Revenue: US$348.1m (up 17% from 3Q 2021). Net...
Simply Wall St. · 11/09 10:26
Omnicell (OMCL) Q3 Earnings Beat Estimates, Guidance Cut
Rise in operating expenses result in an operating loss in Q3 for Omnicell (OMCL), placing significant pressure on the bottom line.
Zacks · 11/07 15:16
Wells Fargo Maintains Overweight on Omnicell, Lowers Price Target to $71
Benzinga · 11/04 16:08
More
About OMCL
Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming the pharmacy care delivery model through automation designed to replace manual, error-prone processes, combined with a single, cloud-based platform and advanced services offerings. The Company's point-of-care automation solutions are designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company's Omnicell Interface Software provides interface and integration between its medication-use products or its supply products and a healthcare facility's in-house information management systems. The Company's Central Pharmacy IV Compounding Service offers a range of service model inclusive of IV robotic technology, data analytic tools, and clinical support for insourced sterile compounding programs.

Webull offers kinds of Omnicell, Inc. stock information, including NASDAQ:OMCL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OMCL stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading OMCL stock methods without spending real money on the virtual paper trading platform.